Lillian Siu, MD, FRCPC
Staff Medical Oncologist
Associate Professor, University of Toronto
Princess Margaret Hospital
Bras Family Drug Development Program
610 University Avenue, Suite 5-718
Toronto, Ontario
M5G 2M9

Tel: 416-946-2911
Fax: 416-946-4467

Dr. Lillian Siu is a staff physician in the Department of Medical Oncology and Hematology at Princess Margaret Hospital since 1998, and is an associate professor at the University of Toronto. Dr. Siu is Director of the Phase I Program and Co-Director of the Robert and Maggie Bras and Family Drug Development Program at Princess Margaret Hospital. She graduated from the University of Toronto, Faculty of Medicine in 1991. After her Fellowship in Medical Oncology at Princess Margaret Hospital, she completed Drug Development Fellowships at the Princess Margaret Hospital and at the University of Texas Science Center, San Antonio.

Dr. Siu's major research focus is in the area of new anticancer drug development, particularly with respect to phase I trials and head and neck malignancies. She is principal investigator of many phase I, II and III trials supported by NCI, NCIC and the pharmaceutical industry. She is the principal investigator of a phase I cooperative agreement U01 award (2008-2013) sponsored by the United States NCI which aims to expedite the access and evaluation of novel anti-cancer agents for patients, optimize clinical trials design of new agents, and characterize the effects of new agents on their targets with clinically relevant endpoints, through the integration of suitable biochemical, pathological, immunological, molecular, and/or imaging methods. The Princess Margaret Hospital Phase I Consortium is the only recipient of this award outside of the United States.

Dr. Siu is the recipient of numerous awards such as the Elsie Winifred Crann Award at the University of Toronto in 2001, Teaching Awards in the Medical Oncology Fellowship Training Program for five consecutive years. Nationally, Dr. Siu has been the co-chair of the NCIC CTG Data Safety Monitoring Committee. Internationally, Dr. Siu has been a member of the AACR International Membership Committee, the ASCO Head and Neck Cancer Scientific Program Committee, and the EORTC Protocol Review Committee. She is the current Neuroendocrine Tumor Task Force Chair in the Gastrointestinal Intergroup Scientific Steering Committee. Dr. Siu has a strong background in clinical trial methodology and has been a member of the Program Committees for both the FECS/ASCO/AACR workshop in Flims, Switzerland and the AACR/ASCO workshop in Vail, Colorado for the past few years. Both workshops focus on the training of young researchers in clinical cancer research methods.

Dr. Siu has published 100 peer-reviewed manuscripts in journals including Journal of Clinical Oncology and Clinical Cancer Research. She is on the Editorial Board of Investigational New Drugs and Journal of Clinical Oncology.